Pediatrix Medical Group/$MD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pediatrix Medical Group
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Ticker
$MD
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
4,120
ISIN
US58502B1061
Website
MD Metrics
BasicAdvanced
$1.1B
-
-$0.99
1.27
-
Price and volume
Market cap
$1.1B
Beta
1.27
52-week high
$17.67
52-week low
$6.62
Average daily volume
948K
Financial strength
Current ratio
1.814
Quick ratio
1.972
Long term debt to equity
83.037
Total debt to equity
83.037
Interest coverage (TTM)
5.04%
Profitability
EBITDA (TTM)
225.265
Gross margin (TTM)
23.38%
Net profit margin (TTM)
-4.17%
Operating margin (TTM)
10.02%
Effective tax rate (TTM)
-1.59%
Revenue per employee (TTM)
$480,000
Management effectiveness
Return on assets (TTM)
5.95%
Return on equity (TTM)
-10.01%
Valuation
Price to revenue (TTM)
0.577
Price to book
1.45
Price to tangible book (TTM)
-2.47
Price to free cash flow (TTM)
5.872
Free cash flow yield (TTM)
17.03%
Free cash flow per share (TTM)
232.11%
Growth
Revenue change (TTM)
-1.13%
Earnings per share change (TTM)
15.55%
3-year revenue growth (CAGR)
0.50%
10-year revenue growth (CAGR)
-2.37%
3-year earnings per share growth (CAGR)
-2.72%
10-year earnings per share growth (CAGR)
-11.27%
What the Analysts think about MD
Analyst ratings (Buy, Hold, Sell) for Pediatrix Medical Group stock.
Bulls say / Bears say
Pediatrix Medical Group's strategic exit from non-core office-based practices is projected to enhance annual Adjusted EBITDA by approximately $30 million, indicating a focused approach to core hospital-based services. (businesswire.com)
The company's stock has surged 80.9% over the past six months, significantly outperforming the industry average, suggesting strong investor confidence and potential for continued growth. (nasdaq.com)
Analysts have set a consensus 12-month price target of $18.36 for Pediatrix Medical Group, representing a potential upside of over 30% from the current share price, reflecting positive market sentiment. (simplywall.st)
Pediatrix Medical Group reported a net loss of $124 million in Q4 2023, raising concerns about its profitability and financial stability. (finance.yahoo.com)
The company's return on capital employed has remained flat over the past five years, despite a 62% reduction in capital employed, indicating potential inefficiencies and challenges in generating returns. (finance.yahoo.com)
Analysts have been regularly downgrading their EPS expectations for Pediatrix Medical Group over the past 12 months, suggesting a bearish outlook on the company's future earnings potential. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
MD Financial Performance
Revenues and expenses
MD Earnings Performance
Company profitability
MD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pediatrix Medical Group stock?
Pediatrix Medical Group (MD) has a market cap of $1.1B as of June 27, 2025.
What is the P/E ratio for Pediatrix Medical Group stock?
The price to earnings (P/E) ratio for Pediatrix Medical Group (MD) stock is 0 as of June 27, 2025.
Does Pediatrix Medical Group stock pay dividends?
No, Pediatrix Medical Group (MD) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Pediatrix Medical Group dividend payment date?
Pediatrix Medical Group (MD) stock does not pay dividends to its shareholders.
What is the beta indicator for Pediatrix Medical Group?
Pediatrix Medical Group (MD) has a beta rating of 1.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.